Pure Global

CITEST - Multi-Drug 3 Drugs Rapid Test Cassette (Urine) (MOP300/AMP1000/THC50) - Indonesia BPOM Medical Device Registration

CITEST - Multi-Drug 3 Drugs Rapid Test Cassette (Urine) (MOP300/AMP1000/THC50) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20103420208. The device is manufactured by CITEST DIAGNOSTICS INC from Canada, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is CAKRA MEDIKA UTAMA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : C
CITEST - Multi-Drug 3 Drugs Rapid Test Cassette (Urine) (MOP300/AMP1000/THC50)
Analysis ID: AKL 20103420208

Risk Classification

Kelas Resiko : C

Product Class

Kelas : 2

Country of Origin

Canada

Authorized Representative

CAKRA MEDIKA UTAMA

AR Address

FORESTA BUSINESS LOFT 6 No. 10, Jl. Raya Boulevard Utara BSD City, Desa/Kelurahan Lengkong Kulon

Registration Date

Jul 31, 2024

Expiry Date

Mar 25, 2027

Product Type

Clinical Toxicology Test System

Multi parameter clinical toxicology test system

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing